Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04549142 · ClinicalTrials.gov registry record

Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure

A clinical trial, sponsored by Stanford University.

Completed
Registry status
400
Enrollment target

NCT04549142: Completed study, sponsored by Stanford University.

NCT04549142 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04549142 has completed, sponsored by Stanford University.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

The purpose of this project is to study the effects of air pollution toxicants on pregnant mothers' immune health during and after pregnancy. Using already collected samples, this study proposes to evaluate changes in immune function in response to air pollution with the use of innovative technologies, to identify the drivers of immune dysfunction and potential modifiable factors, and to determine how these immune findings are associated with pollution exposure and outcomes of disease.

Interventions

  • OTHER There is no intervention

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-08-01
Est. Completion 2023-06-12
Stanford University

1,744 total trials

What the finished NCT04549142 record still lists

NCT04549142 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which There is no intervention is the first listed.

NCT04549142 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04549142 about?

NCT04549142 is a clinical study titled "Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure". The purpose of this project is to study the effects of air pollution toxicants on pregnant mothers' immune health during and after pregnancy. Using already collected samples, this study proposes to evaluate changes in immune function in response to air pollution with the use of innovative technolog...

What is the current status of trial NCT04549142?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2020-08-01. Estimated completion is 2023-06-12.

What interventions are being tested in trial NCT04549142?

The interventions under investigation include: There is no intervention (OTHER).

Who is sponsoring clinical trial NCT04549142?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04549142, the US trial registry maintained by the National Library of Medicine. NCT04549142 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.